The Selective Sphingosine 1-Phosphate Receptor Modulator Etrasimod Regulates Lymphocyte Trafficking and Alleviates Experimental ColitisHussien Al‐Shamma, John W. Adams, H. Kiyomi Komori et al.|Journal of Pharmacology and Experimental Therapeutics|2019Cited by 50
Etrasimod (APD334), an Oral, Next‐Generation Sphingosine‐1‐Phosphate Receptor Modulator Inhibits the Development of Colitis in Lymphoid‐Null Mice Injected with Colitogenic CD4+ T CellsJohn Adams, Hussien Al‐Shamma, Michelle Solomon et al.|The FASEB Journal|2017Cited by 2